Breast Cancer Clinical Trial
Official title:
Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment
| Verified date | September 2015 |
| Source | Université Libre de Bruxelles |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Belgium: Jules Bordet Institute |
| Study type | Interventional |
Background: The end of treatment is for cancer patients the beginning of a critical
rehabilitation period including numerous physical, emotional, professional and cognitive
challenges. Specific interventions adapted to this post-treatment period need thus to be
designed. Interventions such as group cognitive-behavioral therapy and hypnosis have been
shown to be effective. However, moderate effect sizes, no comprehensive description of the
treatment interventions and assessments relying only on self-report measures warrant further
investigation. This study aims to assess, in breast cancer patients at the end of treatment,
the impact of a group intervention combining cognitive-behavioral therapy and hypnosis
versus a group intervention on patient's adjustment and emotion self-regulation.
Design: This is a two-armed, longitudinal, randomized controlled trial. Breast cancer
patients finishing their radiation therapy treatment will be randomized to either an
immediate group intervention combining cognitive-behavioral therapy and hypnosis or a group
intervention. Patients will be assessed at three time points during the first year following
the end of treatment: at 1 (T1), 6 (T2) and 12 (T3) months after the end of treatment.
Patients' adjustment will be assessed through questionnaires. Patient emotion
self-regulation ability will be assessed through their ability to respond both subjectively
(self-reported emotional state) and objectively (heart rate) to two emotion self-regulation
tasks.
Discussion: It is hypothesized that a group intervention combining cognitive-behavioral
therapy and hypnosis will be more effective than a group intervention. Results of this study
will contribute to improving post-treatment care for breast cancer patients.
| Status | Completed |
| Enrollment | 260 |
| Est. completion date | September 2015 |
| Est. primary completion date | September 2015 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Non-metastatic breast cancer (in situ or invesive) - End of active treatments (surgery, chemotherapy and radiotherapy) - No recurrence nor palliative care - Min. 18 years - Able to speak French - Willing to be randomized to study intervention group - Accept to give their written informed consent Exclusion Criteria: - No cognitive dysfunction - No severe or uncontrolled psychiatric illness |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Belgium | Institut Jules Bordet | Brussels |
| Lead Sponsor | Collaborator |
|---|---|
| Université Libre de Bruxelles | Jules Bordet Institute |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Physical wellbeing: emotion regulation ability (heart rate, relaxation, quality of life,...) | Questionnaires: Quality of life questionnaires: "EORTC QLQ-C30" and "EORTC-BR23" Edmonton symptom evaluation scale Way of life questionnaire |
Change from baseline in heart rate and relaxation ability at 6 (T2) and 12 months (T3) | No |
| Primary | Psychological wellbeing: emotional state, emotional adjustment, social adjustment, quality of life,... | Questionnaires: the Hospital Anxiety and Depression Scale the Rosenberg's Self-Esteem the Mental Adjustment to Cancer Scale the Fear of Cancer Recurrence Inventory the Perceived Social Support Questionnaire the Courtauld Emotional Control scale the Ways of Coping Checklist the Toronto Alexithymia Scale a questionnaire about usual emotional state a questionnaire about the use of relaxation techniques and self-hypnosis |
Change from baseline in emotional state, emotional adjustment, social adjustment and quality of life at 6 (T1) and 12 (T2) months. | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |